Layer A — cited: COA practices, testing, enforcement, provenanceLayer B — disclaimed: online sentiment, community reportsIndependence firewall: the Trust Index is computed from cited facts only — never sold, never sorts the directory.

V0 · V1 · V2 · V3 · V4

Overview

Independence-firewalled vendor profile · Trust Index computed from cited facts

CordenPharma

cordenpharma.comUnder reviewResearch use only

US-facing research-peptide supplier, pharmaceutical-grade, founded 2006. Publishes certificates of analysis. Identity and claims are vendor-stated unless cited. Research use only.

Publishes COAsGMP claim

—products listed

—Trustpilot

2006founded

Communityconfidence

2026-06-27 as of

Vendor Trust Index

/100

Provisional — Insufficient Data

Not enough cited data to compute a Trust Index. Absence of evidence is not evidence of badness.

Coverage65%

ConfidenceModerate

Cited facts43

A transparency readout of 43 cited facts — never sold, never sorts the directory; not a safety verdict (RUO). How it’s computed →

Catalog breadth

—

No data available

External rating

—

No data available

COA policy

Cited

Yes

publishes COAs

Operating status

Cited

Under review

as of 2026-06-27

Trust Index breakdown

DerivedV3

The Trust Index weighs five evidence pillars — purity claims-vs-reality, testing transparency, enforcement conduct, operational accountability and reputation integrity — into a single 0–100 factor. Nothing here can be bought.

Provisional — Insufficient Data. This listing is under review; the Trust Index is withheld until verification completes. A precise number is withheld rather than guessed — absence of evidence is never shown as a low score.

Evidence at a glance

DerivedV3

Products listed: No data available
Publishes COAs: Yes
Independent tests tracked: 0
Enforcement records: 0
Cited sources: 43

Methodology & independence

CitedV4

The Trust Index is computed only from cited facts — and can never be bought.
Sponsorship & affiliate are excluded by construction — they never move the score, sort, or inclusion.
Facts are dated and cited; absent data lowers confidence, never the score (absence isn’t evidence of bad).

No affiliate relationship with this vendor.

Legitimacy signals

DerivedV2

Official domain: cordenpharma.com
Payment: Not disclosed
Third-party testing: Not confirmed
Published COAs: Yes
HQ disclosed: US-CO
Sponsored placement: No

Vendor details

CitedV1

Founded (claimed): 2006
HQ: US-CO
Address: Aeschenvorstadt 71, 4051 Basel, Switzerland
Ships from: US
Ships to: US, international
Categories: Peptide APIs · Oligonucleotides · Lipid excipients / LNPs · Sterile injectables · Small-molecule APIs · Oral solid dosage
Grade claimed: pharmaceutical
Website: cordenpharma.com

WHOIS: The CordenPharma brand dates to 2006, when International Chemical Investors Group (ICIG) consolidated the platform; the company marked a 20-year milestone around 2026 (per third-party aggregators). The Boulder, CO peptide site itself predates the CordenPharma brand (legacy large-scale peptide API plant). German group entity: Corden Pharma International GmbH, Plankstadt (Amtsgericht Mannheim HRB 701567). WHOIS for cordenpharma.com was not retrieved this crawl. northdata.com

Find them

Verify you are on cordenpharma.com — 2 domain variants exist; this is the one on record as current.

V5 · V6 · V7 · V8 · V9

Products & price

Pricing & listings are not in the seed yet — shipping facts are

Product catalog & pricelist

No data availablePrice-per-mg data has not been collected for this vendor.

Price-per-mg snapshot

No data availableNo price series collected.

Deals & bulk pricing

No data availableNo promotional or bulk pricing collected.

Price snapshot

No data availableRequires price data.

Shipping & fulfillment

CitedV9

Ships from: US
Ships to: US, international
Domestic shipping: No data available
Ship speed: No data available
Payment: No data available

Watch & alerts

V30

Status-change & enforcement alerts
Add to a comparison set

V10 · V11 · V12

Quality & COA verification

COA & testing practices

CitedV10

What this vendor proves about identity, purity & potency

Publishes COAs

policy on record

Third-party tested

not on record

Independent tests tracked

not on record

GMP / ISO claim

vendor-claimed

As a cGMP contract manufacturer of pharmaceutical APIs, CordenPharma produces batch-specific Certificates of Analysis for its pharma/biotech customers under regulated GMP quality systems; there is NO public, consumer-facing per-vial COA program because CordenPharma does not sell finished research vials to individuals. Its quality system is verified by regulatory inspection (FDA, EMA, PMDA, ANVISA) rather than by independent purity-aggregator testing of consumer product.

Methods: cGMP analytical testing within a regulated quality system (vendor-stated capabilities span the API-to-drug-product chain). The Boulder, CO API site and other facilities are inspected by global regulators including FDA, EMA and PMDA (vendor-stated); CordenPharma Colorado also reported an October 2025 ANVISA inspection and a November 2025 FDA inspection, both with no observations. Not comparable to consumer third-party purity testing (e.g. Janoshik/Finnrick)..

COA repository · published lab results

No data availablePer-lot COA records have not been collected.

Independent test results

V11

No data availableNo independent assays tracked for this vendor.

Authenticity & anti-spoofing

CitedV12

Official domain: cordenpharma.com

Only order from the official domain. Research-chem vendors are frequently impersonated by typosquats — verify the URL before purchase.

Known domain variants

cordenpharma.com — official · Primary corporate/CDMO site for the global group
cordenpharmacolorado.com — variant · Referenced as the Colorado site's local web presence in a search result; not independently re-confirmed (unverified)

V13 · V14 · V15 · V16 · V17

Reputation & sentiment

Online sentiment

Community signalUGC · disclaimedV13

Forum sentiment: unknown · unverified

A coarse community read, not a measured score. Platforms can be gamed — corroborate.

Reddit & community

UGC · disclaimedV14

No data availableCommunity mentions are not collected for this vendor.

Review sites

UGC · disclaimedV15

1 platforms on record — scores differ by scale; read the notes

BBB (Corden Pharma Colorado, Inc.)—

Listed as a Boulder, CO 'Pharmaceutical Manufacturing' business — a B2B manufacturer entry, not a consumer retail rating. No consumer-review score captured.

Not applicable in the consumer sense. CordenPharma is a B2B pharmaceutical CDMO, so it has no Trustpilot/consumer-review footprint, no peptide-community (Reddit/forum) sentiment, and no scam-report history. Its 'reputation' is industry/regulatory: large pharma manufacturing contracts (reported ~EUR 3bn long-term GLP-1 backlog), clean FDA/ANVISA inspections (Nov/Oct 2025), and trade-press coverage of multi-hundred-million-euro expansions.

pharmasource.global

User reviews

Not collectedUGC · disclaimedV16

No data availableNo first-party reviews have been collected for this vendor.

Press & media

CitedV17

Astorg to acquire leading pharmaceutical CDMO CordenPharma from ICIG (Bloomberg reported ~$2.6bn)

Astorg / Bloomberg / FiercePharma · 2022-05-02

bloomberg.com

WACKER and CordenPharma to produce mRNA vaccines for Germany when needed (pandemic-preparedness consortium)

CordenPharma / Wacker / Contract Pharma · 2022-04-13

cordenpharma.com

WACKER & CordenPharma consortium enters pandemic-readiness stand-by phase (mRNA fill & finish, lipids/LNP) for the German government

Wacker Chemie AG · 2024-06-01

wacker.com

CordenPharma invests ~EUR 900m (~$980m) in transformational peptide-platform expansion across the USA & Europe for GLP-1 demand

CordenPharma / PR Newswire / Manufacturing Dive · 2024-07-16

prnewswire.com

CordenPharma to build >EUR 500m greenfield peptide facility near Basel, Switzerland (Muttenz / Getec Park)

CordenPharma / PR Newswire · 2025-02-19

prnewswire.com

CordenPharma Colorado completes FDA and ANVISA inspections with no observations (FDA: no Form 483, 'No Action Indicated')

PharmaSource / CordenPharma · 2025-11-14

pharmasource.global

BioMed Realty and CordenPharma Colorado team up to expand peptide development lab (64,000 sq ft, LEED Gold) at Flatiron Park, Boulder

BusinessWire / Pharmaceutical Technology · 2026-03-04

businesswire.com

CordenPharma acquires peptide CDMO AmbioPharm (North Augusta, SC + Shanghai; ~400 staff) to expand global peptide API capacity

CordenPharma / PR Newswire / BioSpace · 2026-05-27

prnewswire.com

V18 · V19 · V20 · V21

Trust, risk & enforcement

Enforcement & legal history

CitedV18

Warning letters, raids, shutdowns, BBB actions — cited or omitted

No enforcement actions on record. No FDA warning letters, raids, recalls, or import alerts naming this vendor as of 2026-06-27. Absence of record is not a guarantee.

We publish negative records only with a source, and offer vendors a right of reply.

Buyer safety checklist

DerivedV19

Publishes COAs
Third-party tested
Accepts non-crypto payment
Has reship / refund policy
Clean enforcement record
Currently operating

3 of 6 checks clear · derived from vendor-stated data.

Operating status & continuity

CitedV20

Status: Under review
Last confirmed: 2026-06-27
US-facing: Yes
Domain history: 2 variants on record
Known rebrands / aliases: None on record

The CordenPharma brand dates to 2006, when International Chemical Investors Group (ICIG) consolidated the platform; the company marked a 20-year milestone around 2026 (per third-party aggregators). The Boulder, CO peptide site itself predates the CordenPharma brand (legacy large-scale peptide API plant). German group entity: Corden Pharma International GmbH, Plankstadt (Amtsgericht Mannheim HRB 701567). WHOIS for cordenpharma.com was not retrieved this crawl.

If they disappear: prepaid / crypto orders carry no recourse if any research-chem vendor changes domains or shuts down with little notice.

Scam & non-delivery reports

Community-reportedUGC · disclaimedV21

No data availableCommunity scam/non-delivery reports are not collected for this vendor.

V22 · V23 · V24

Compare & discover

Compare vendors

V22

See CordenPharma side-by-side with every vendor on the directory — COA practices, testing, shipping, enforcement history.

Similar vendors

V23

No data availableSimilar-vendor matching is not yet computed.

Best value for

V24

Cross-vendor price ranking is intentionally not computed

The Trust Index rates each vendor against a fixed evidence rubric — it never ranks vendors against each otheror sorts the directory. Naming a “best-value” vendor per compound would require exactly that cross-vendor sort, so we don’t. Compare the cited price-per-mg in the Products & price table yourself, or open a side-by-side comparison.

V25 · V26 · V27 · V28 · V29 · V31

Compliance, meta & tools

Jurisdiction & legality

CitedV25

Ships to: US, international
US-facing: Yes
Gating: Commercial links suppress where a compound is restricted in your region

Commercial CTAs are jurisdiction-gated; reference content stays visible everywhere (RUO).

Independence & disclosure

CitedV26

Affiliate: No
Sponsored placement: None
Effect on Trust Index: None — sponsorship & affiliate are excluded by construction

No affiliate or sponsorship relationship on record.

Data confidence & provenance

CitedV27

Reviewed by: PeptideCompass editorial
Sources: 43 cited
Captured: 2026-06-27
Provenance: web_research

View 43 sources

FAQ

CitedV31

Can I buy peptides directly from CordenPharma?

No. CordenPharma is a business-to-business contract development & manufacturing organization (CDMO) that produces peptide active pharmaceutical ingredients (APIs) and finished drug products under contract for pharmaceutical and biotech companies. It does not operate a consumer/research storefront, does not list products or prices publicly, and does not sell research vials to individuals. Research use only.

cordenpharma.com

Is CordenPharma a legitimate manufacturer?

Yes. CordenPharma is a large, established global cGMP CDMO. Its Colorado (Boulder) peptide API site is described as one of the largest solid-phase peptide synthesis (SPPS) operations worldwide, it holds major long-term GLP-1 peptide manufacturing contracts, and its sites are inspected by global regulators (FDA, EMA, PMDA). CordenPharma Colorado reported an October 2025 ANVISA inspection and a November 2025 FDA inspection, each with no observations (no Form 483; FDA 'No Action Indicated'). PeptideCompass computes no vendor score. Research use only.

pharmasource.global

Who owns CordenPharma?

European private-equity firm Astorg agreed to acquire CordenPharma from International Chemical Investors Group (ICIG) in May 2022 (Bloomberg reported a deal value of about $2.6 billion); the company has operated as a standalone Astorg-backed business since 2022, with founders reinvesting. Research use only.

bloomberg.com

Citable summary (GEO)

DerivedV29

CordenPharma (cordenpharma.com) is a US-facing research-peptide vendor. Publishes certificates of analysis. No enforcement actions on record. PeptideCompass Trust Index: Provisional — Insufficient Data — This listing is under review; the Trust Index is withheld until verification completes.. Data is community and dated 2026-06-27. The Trust Index is an evidence-transparency readout of cited facts — not a safety verdict, never sold. Research use only.

JSON-LD: Organization · BreadcrumbList · FAQPage. Computed from cited facts, never sold.

Contribute, report & claim

V28

Reports are moderated · not verified by PeptideCompass